Table 4.
Cell | Treatment | Effects | Reference |
---|---|---|---|
3T3-L1 adipocytes | CA 3 µM, COH 3 µM | ↓ differentiation | [40] |
↑ intracellular GSH | |||
3T3-L1 adipocytes | Acetone RE 10–30 μg/mL CA 0.3–20 μM |
Inhibited adipocyte differentiation ↔ cell viability |
[41] |
3T3-L1 adipocytes | RE 50 µg/mL | ↑ intracellular lipid | [42] |
↑ glucose uptake | |||
3T3-L1 adipocytes | CA 0.1–10 µM | ↓ intracellular lipid accumulation | [43] |
↓ TG content (15.5–39.8%) | |||
↓ GPDH activity | |||
↔ cell viability | |||
3T3-L1 adipocytes pretreated with LPS | CA 0–20 µM | ↓ mRNA expression of TNFα, IL-6 and MCP-1 | [44] |
↓ TLR4 protein expression | |||
↓ Phospho-ERK levels | |||
↓ NF-κB activation |